...
首页> 外文期刊>International journal of molecular medicine >Baicalin attenuates inflammation in mice with OVA-induced asthma by inhibiting NF-B and suppressing CCR7/CCL19/CCL21
【24h】

Baicalin attenuates inflammation in mice with OVA-induced asthma by inhibiting NF-B and suppressing CCR7/CCL19/CCL21

机译:黄ical苷通过抑制NF-B和抑制CCR7 / CCL19 / CCL21减轻OVA诱发的哮喘小鼠的炎症

获取原文
获取原文并翻译 | 示例

摘要

Baicalin, extracted and purified from the Chinese medicinal plant, Scutellaria baicalensis Georgi (Huang qin in Chinese), exhibits potent anti-inflammatory activity against asthma. However, it remains unknown whether baicalin inhibits the activity of CC chemokine receptor 7 (CCR7) and its ligands, which are crucial for the initiation of airway inflammation. In the present study, we investigated the effects of baicalin on CCR7 and its ligands, CCL19 and CCL21, as well as on the nuclear factor-B (NF-B) pathway in a mouse model of asthma. A mouse model of acute asthma was established by exposing the mice to ovalbumin (OVA) (by intraperitoneal injection and inhalational challenge). Within 24 h of the final OVA challenge, lung function was detected by direct airway resistance analysis. Lung tissues were examined for pathological changes. Inflammatory cell counts in bronchoalveolar lavage fluid (BALF) were assessed. ELISA was utilized to evaluate the OVA-IgE, CCL19 and CCL21 levels in BALF. The interleukin (IL)-6 and tumor necrosis factor (TNF)- levels in serum were also detected by ELISA. The protein expression levels of CCR7, as well as that of phosphorylated IB (p-IB) and phosphorylated p65 (p-p65) were determined by western blot analysis and RT-qPCR was used to determine the CCR7 mRNA levels. Our data demonstrated that the oral administration of baicalin significantly improved pulmonary function and attenuated inflammatory cell infiltration into the lungs. Baicalin also decreased the levels of OVA-IgE, IL-6, TNF- and CCR7, as well as those of its ligand, CCL19; the levels of NF-B were also markedly suppressed by baicalin. The CCR7 mRNA level was substantially decreased. Our results thus suggest that baicalin exerts an inhibitory effect on airway inflammation, and this effect may be associated with the inhibition of CCR7 and CCL19/CCL21, which may provide new mechanistic insight into the anti-inflammatory effects of baicalin.
机译:从中草药黄cut(Scutellaria baicalensis Georgi)提取并纯化的黄ical苷具有有效的抗炎活性。然而,仍然不知道黄ical苷是否抑制CC趋化因子受体7(CCR7)及其配体的活性,这对于引发气道炎症至关重要。在本研究中,我们调查了黄ical苷对哮喘小鼠的CCR7及其配体CCL19和CCL21以及对核因子B(NF-B)途径的影响。通过将小鼠暴露于卵白蛋白(OVA)(腹膜内注射和吸入激发)建立了急性哮喘小鼠模型。在最终OVA攻击后24小时内,通过直接气道阻力分析检测到肺功能。检查肺组织的病理变化。评估支气管肺泡灌洗液(BALF)中的炎症细胞计数。 ELISA用于评估BALF中的OVA-IgE,CCL19和CCL21水平。 ELISA还检测血清中白介素(IL)-6和肿瘤坏死因子(TNF)的水平。通过蛋白质印迹分析确定CCR7的蛋白质表达水平,以及磷酸化的IB(p-IB)和磷酸化的p65(p-p65)的蛋白质表达水平,并使用RT-qPCR确定CCR7 mRNA的水平。我们的数据表明,口服黄in苷可显着改善肺功能,并减少炎症细胞向肺的浸润。黄ical苷还降低了OVA-IgE,IL-6,TNF-和CCR7及其配体CCL19的水平。黄ical苷也可显着抑制NF-B的水平。 CCR7 mRNA水平大大降低。因此,我们的结果表明黄ical苷对气道炎症具有抑制作用,并且这种作用可能与CCR7和CCL19 / CCL21的抑制有关,这可能为黄ical苷的抗炎作用提供新的机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号